Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,898 | 688 | 99.3% |
| Education | $106.25 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,366 | 68 | $0 (2024) |
| ABBVIE INC. | $1,321 | 67 | $0 (2024) |
| Esperion Therapeutics, Inc. | $1,264 | 52 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,182 | 41 | $0 (2024) |
| PFIZER INC. | $904.25 | 45 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $872.97 | 46 | $0 (2024) |
| Merck Sharp & Dohme LLC | $597.65 | 25 | $0 (2024) |
| Novo Nordisk Inc | $595.02 | 29 | $0 (2024) |
| Lilly USA, LLC | $577.94 | 29 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $533.40 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,396 | 244 | PFIZER INC. ($513.23) |
| 2023 | $4,194 | 192 | Regeneron Healthcare Solutions, Inc. ($546.08) |
| 2022 | $2,934 | 145 | Esperion Therapeutics, Inc. ($315.96) |
| 2021 | $1,452 | 71 | Esperion Therapeutics, Inc. ($344.58) |
| 2020 | $368.84 | 21 | Lilly USA, LLC ($101.53) |
| 2019 | $323.11 | 8 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($240.92) |
| 2018 | $167.48 | 7 | Avanir Pharmaceuticals, Inc. ($109.25) |
| 2017 | $168.80 | 3 | Avanir Pharmaceuticals, Inc. ($124.99) |
All Payment Transactions
691 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Gastroenterology | ||||||
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $10.59 | General |
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Immunology | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: PAIN | ||||||
| 12/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Gastroenterology | ||||||
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: PAIN | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.66 | General |
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: PAIN | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Respiratory | ||||||
| 12/08/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.80 | General |
| Category: GI | ||||||
| 12/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.80 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/22/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $97.85 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,032 | 3,016 | $292,487 | $191,064 |
| 2022 | 13 | 820 | 2,237 | $203,320 | $139,550 |
| 2021 | 18 | 1,114 | 2,298 | $174,719 | $125,018 |
| 2020 | 16 | 812 | 2,578 | $217,368 | $144,181 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 190 | 859 | $112,011 | $76,489 | 68.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2023 | 188 | 679 | $47,991 | $28,761 | 59.9% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 209 | 807 | $45,813 | $27,784 | 60.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 249 | $30,134 | $17,663 | 58.6% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 72 | 85 | $19,375 | $13,870 | 71.6% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 98 | 116 | $19,020 | $13,482 | 70.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 93 | 113 | $10,302 | $7,346 | 71.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 14 | 15 | $2,460 | $1,962 | 79.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 24 | 24 | $2,748 | $1,750 | 63.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 23 | $960.00 | $810.56 | 84.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 16 | 16 | $720.55 | $532.12 | 73.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $472.00 | $436.92 | 92.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 16 | $480.00 | $177.06 | 36.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 136 | 537 | $61,418 | $44,471 | 72.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2022 | 134 | 515 | $36,944 | $24,373 | 66.0% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 155 | 583 | $33,082 | $23,030 | 69.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 243 | $29,465 | $17,676 | 60.0% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 78 | 84 | $18,258 | $12,584 | 68.9% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 70 | 75 | $10,028 | $7,137 | 71.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 94 | 107 | $9,236 | $6,503 | 70.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 17 | 18 | $2,007 | $1,422 | 70.9% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 20 | 20 | $900.95 | $632.60 | 70.2% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 13 | 13 | $650.00 | $610.16 | 93.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 19 | $580.00 | $567.66 | 97.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $430.00 | $417.42 | 97.1% |
About Dr. Wu Tan, MD
Dr. Wu Tan, MD is a Internal Medicine healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/27/2011. The National Provider Identifier (NPI) number assigned to this provider is 1518236181.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wu Tan, MD has received a total of $15,004 in payments from pharmaceutical and medical device companies, with $5,396 received in 2024. These payments were reported across 691 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($14,898).
As a Medicare-enrolled provider, Tan has provided services to 3,778 Medicare beneficiaries, totaling 10,129 services with total Medicare billing of $599,813. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Flushing, NY
- Active Since 12/27/2011
- Last Updated 09/25/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518236181
Products in Payments
- DUPIXENT (Biological) $1,694
- NURTEC ODT (Drug) $1,215
- XIFAXAN (Drug) $1,199
- NEXLETOL (Drug) $1,116
- Kerendia (Drug) $533.40
- CAPLYTA (Drug) $494.09
- UBRELVY (Drug) $443.06
- Vascepa (Drug) $411.36
- VRAYLAR (Drug) $400.82
- Livalo (Drug) $396.29
- Ozempic (Drug) $386.73
- Linzess (Drug) $382.16
- FARXIGA (Drug) $334.37
- QUVIVIQ (Drug) $279.36
- JARDIANCE (Drug) $272.03
- QULIPTA (Drug) $268.40
- NUEDEXTA (Drug) $249.19
- EVENITY (Biological) $239.50
- VERQUVO (Drug) $235.50
- BELSOMRA (Drug) $227.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Flushing
Calvin Pan, M.d, M.D
Internal Medicine — Payments: $975,186
Ari Bunim, Md, MD
Internal Medicine — Payments: $361,039
Glenn Turett, M.d, M.D
Internal Medicine — Payments: $231,558
Weining Liang, Md, MD
Internal Medicine — Payments: $180,077
Dr. Yong Yu, M.d, M.D
Internal Medicine — Payments: $144,144
Dr. John Sciales, M.d, M.D
Internal Medicine — Payments: $92,715